Table 4.
MHD patients A−D− |
MHD patients A+D− |
MHD patients A−D+ |
MHD patients A+D+ |
Differences among MHD patients* p value |
Normal controls A−D− |
|
---|---|---|---|---|---|---|
N (male/female) | 30 (18/12) | 14 (8/6) | 11 (10/1) | 17 (13/4) | 0.182 | 36 (20/16) |
Age, years | 50.3±13.8 | 54.5±10.4 | 52.8±12.6 | 53.6±14.0 | 0.726 | 50.3±12.6 |
% Diabetic | 23 | 50 | 36 | 65 | 0.037 | 0 |
6-MWD(meters) | 466±119 | 397±116 | 478±124 | 410±122 | 0.013 | 620±65† |
Sit-to-stand test (cycles per 30 seconds) | 16±5 | 17±5 | 18±5 | 13±5 | 0.544 | 26±6† |
Stair climbing test (seconds per 22 stairs) | 14.7±7.0a | 16.2±10.0 | 13.1±2.7b | 19.2±18.5a,b | <0.0001 | 9.7±1.1† |
Symbols are defined in the legends to Table 3.
Anxiety and depression in this table is determined by the Beck Anxiety Inventory and Beck Depression Inventory, respectively. The thresholds for diagnosing mild or more severe anxiety or depression are adapted from Beck et al (6,7).
Data are presented as mean ± standard deviation. All statistical comparisons are adjusted for age, gender, presence of diabetes, blood hemoglobin, and dialysis vintage.
Determined by ANOVA
Significantly different from values in other columns with the same superscript (p<0.05), as determined by a Tukey’s honestly significant difference (HSD) test for pairwise comparisons
Normal A−D− controls are significantly different from MHD A−D− patients as determined by Tukey’s HSD test: p<0.01.
Table adapted from Zhang et al (10).